NCT01908465View on ClinicalTrials.gov

Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial

PHASE4CompletedINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

November 30, 2013

Primary Completion Date

November 2, 2022

Study Completion Date

November 2, 2022

Conditions

Irritable Bowel Syndrome (IBS)

Interventions

DRUG

Ebastine

DRUG

Placebo

Trial Locations (12)

1061

Sint Lucas Andreas Ziekenhuis, Amsterdam

1105

Academisch Medisch Centrum, Amsterdam

2650

UZ Antwerpen, Edegem

3000

UZ Leuven, Leuven

3600

ZOL (Ziekenhuis Oost-Limburg), Genk

6202

AZ Maastricht, Maastricht

6800

Rijnstate, Arnhem

7500

Medisch Spectrum Twente, Enschede

8310

AZ Sint-Lucas Brugge, Bruges

9000

UZ Gent, Ghent

9620

AZ Sint-Elizabeth Zottegem, Zottegem

1213/1261

Tergooiziekenuizen Blaricum/Hilversum, Blaricum

All Listed Sponsors

lead

KU Leuven

OTHER

NCT01908465 - Peripheral Histamine 1 Receptor Blockade in IBS: Multicenter Trial | Biotech Hunter | Biotech Hunter